Log in
SEARCH
All
News
CPD
CATEGORIES
Upcoming Events
Podcasts
On demand
Acne
Allergy
Autoimmune diseases
Cosmetic dermatology
Dermatitis
Genetic conditions
Hair & nails
Medicines
Medicopolitical
Psoriasis
Public health
Skin cancers
Skin infections
About
About the limbic
Contact
Website Disclaimer
Privacy Policy
Terms & Conditions
news
cpd
Search
All
News
CPD
Account
Saved
SEARCH
All
News
CPD
CATEGORIES
Acne
Allergy
Autoimmune diseases
Cosmetic dermatology
Dermatitis
Genetic conditions
Hair & nails
Medicines
Medicopolitical
Psoriasis
Public health
Skin cancers
Skin infections
Events
Podcasts
On demand
Log out
Dupilumab has potential for chronic actinic dermatitis: report
Dermatitis
Dermatologist ordered to repay almost $2 million by PSR
Medicopolitical
Apremilast use increases for chronic plaque psoriasis: DUSC
Psoriasis
Pharmacogenomic testing advised to avoid hypersensitivity reactions
Allergy
Why the pathology bulk-billing campaign is more about driving industry profits than saving you money
Financial
Pharma funding: which specialties accept the most payments?
Financial
MORE NEWS
Drug survival in psoriasis: which biologic wins out?
Psoriasis
Special report: leadership chaos strikes the RACP
Medical politics
Why medical indemnity is back on the agenda
Financial
Healthcare private equity acquisitions on the rise in Australia
Financial
Institute launches cultural probe amid sexual harassment claims
sexism
RACP boss resigns as college goes into the red
medical education
Urgent regulation needed on ‘risky’ medical AI
e-health
AHPRA clarifies ‘fine line’ on skin surgery ads
Medicopolitical
Melanoma risk calculator improves decisions on adjuvant therapy
Skin cancers
Identifying opioid tapering pathways to safely stop use
Pain
PBS flags high use of dupilumab for atopic dermatitis
Autoimmune diseases
Major update to advice on treatment of psoriatic arthritis
Psoriasis
more news